Nucelion to Develop Exosome Therapies for Eye Diseases with Pandorum
The story in brief
Bharat Biotech’s Nucelion Therapeutics will collaborate with Pandorum Technologies on two PRIP-backed projects targeting advanced keratopathy and wet AMD. The partnership will focus on developing GMP-compliant materials for clinical studies in India and abroad, with Nucelion providing process development and manufacturing support. The projects aim to advance investigational therapies through a common designer-exosome platform.